Glimepirid Stada (Glimepiride)

Glimepirid Stada is indicated for the treatment of type 2 diabetes mellitus when diet, exercise, and other non‑pharmacologic measures are insufficient. It may be used alone or in combination with other antidiabetic agents.

• Improves glycemic control in adults with type 2 diabetes.
• Can be combined with metformin when monotherapy is inadequate.
• May be added to basal insulin regimens to reduce fasting glucose.
• Used as part of a comprehensive diabetes management plan including lifestyle modification.
• Suitable for patients who require an oral sulfonylurea to stimulate insulin secretion.

Glimepirid Stada may cause a range of side effects, some of which are more frequently observed than others.

Common

• Mild hypoglycemia, especially when meals are missed.
• Nausea or abdominal discomfort.
• Headache or dizziness.
• Weight gain due to increased insulin activity.

Serious

• Severe hypoglycemia requiring assistance.
• Allergic reactions such as rash, itching, or swelling.
• Hepatic dysfunction indicated by elevated liver enzymes.
• Hematologic abnormalities like leukopenia or thrombocytopenia.

Before starting Glimepirid Stada, certain precautions should be considered to ensure safe use.

• Assess renal and hepatic function, as impairment may affect drug clearance.
• Monitor blood glucose regularly to detect hypoglycemia early.
• Use caution in elderly patients who may be more susceptible to low blood sugar.
• Discuss pregnancy or breastfeeding plans with a healthcare professional; safety data are limited.
• Review any history of cardiovascular disease, as sulfonylureas may influence cardiac outcomes.
• Avoid abrupt discontinuation without medical guidance to prevent rebound hyperglycemia.

Glimepirid Stada can interact with several medications, altering its effectiveness or safety profile.

Avoid

• Concurrent use with other sulfonylureas or insulin that may increase hypoglycemia risk.
• Strong CYP2C9 inhibitors (e.g., fluconazole, amiodarone) that can raise glimepiride levels.
• MAO inhibitors, which may potentiate hypoglycemic effects.

Use with caution

• Beta‑blockers, as they may mask hypoglycemia symptoms.
• Thiazide diuretics, which can affect glucose tolerance.
• Corticosteroids, which may increase blood glucose and require dose adjustments.
• Antifungal agents like ketoconazole, which may modestly increase drug exposure.